2018 annual financial data
Alaunos Therapeutics 2018 Operating margin
Direct answer
Operating margin was -36,921.92%.
Operating income was -53,906,000 USD and net income was -53,117,000 USD.
Operating cash flow was -49,457,000 USD.
Get free Alaunos Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 146,000 USD
- Operating income
- -53,906,000 USD
- Net income
- -53,117,000 USD
- Operating cash flow
- -49,457,000 USD